Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Inflamm Res. 2013 Aug 22;62(11):10.1007/s00011-013-0657-5. doi: 10.1007/s00011-013-0657-5

Figure 3. Detection of phosphorylated proteins in MCP-1-treated monocytes in the presence/ absence of PKCβ inhibitor peptide.

Figure 3

Human monocyte lysates were fractionated by 2-DIGE and immunoblots were probed with phosphor (Ser) PKC substrate antibody. Figure 3A shows the monocyte group treated with MCP-1 and Figure 3B shows the monocyte group treated with MCP-1+PKCβ inhibitor peptide.